Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
PDL BIOPHARMA, INC. (PDLI)
Sector: Healthcare; Industry: Biotechnology

PDL BioPharma, Inc. acquires, manages, and commercializes commercial stage pharmaceutical assets and late clinical stage pharmaceutical products in North America, Europe, Asia, and internationally. The company operates through Medical Devices, Strategic Positions, Pharmaceutical, and Income Generating Assets segments. The Pharmaceutical segment manufactures, markets, and sells prescription medicine products for the treatment of hypertension to wholesalers under the Tekturna and Tekturna HCT names in the United States, as well as under the Rasilez and Rasilez HCT names internationally. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-01 Silver Point Capital L.P. 10%-Owner Buy 187,061 $2.05 $383,475 No
2020-12-30 Silver Point Capital L.P. 10%-Owner Buy 6,325,213 $2.50 $15,813,032 No
2020-12-30 GRYSKA DAVID W Director Sell 20,000 $2.74 $54,800 No
2020-12-29 Silver Point Capital L.P. 10%-Owner Buy 631,600 $2.69 $1,696,234 No
2020-12-23 Silver Point Capital L.P. 10%-Owner Buy 1,565,000 $2.60 $4,067,400 No
2020-12-22 MCLAUGHLIN JOHN PETER Director Sell 327,934 $2.61 $855,774 No
2020-12-17 Silver Point Capital L.P. 10%-Owner Buy 1,748,000 $2.59 $4,521,780 No
2020-12-16 Stone Christopher Lewis VP, Gen. Counsel & Secretary Sell 200,000 $2.56 $512,000 No
2020-12-16 Monnet Dominique President and CEO Sell 500,000 $2.60 $1,300,000 No
2020-12-16 GRYSKA DAVID W Director Sell 75,000 $2.68 $201,000 No
2020-12-15 Silver Point Capital L.P. 10%-Owner Buy 2,090,000 $2.57 $5,369,300 No
2020-12-03 GRYSKA DAVID W Director Sell 75,000 $2.52 $189,000 No
2020-11-23 O'Farrell Elizabeth G. Director Sell 25,826 $2.44 $63,015 No
2020-11-23 GRYSKA DAVID W Director Sell 50,000 $2.43 $121,500 No
2020-11-18 O'Farrell Elizabeth G. Director Sell 63,291 $2.38 $150,696 No
2020-11-20 Bazaar Alan Lee Director Sell 33,435 $2.42 $81,003 Yes
2020-11-18 GRYSKA DAVID W Director Sell 150,000 $2.40 $359,500 No
2019-06-10 PDL BIOPHARMA, INC. 10%-Owner Buy 6,666,667 $4.50 $30,000,002 Yes
2017-03-24 GARCIA PETER S Vice President, CFO Buy 25,000 $1.98 $49,401 No
2016-08-09 GARCIA PETER S Vice President, CFO Buy 10,000 $3.00 $29,950 No
2015-12-15 GARCIA PETER S Vice President, CFO Buy 15,000 $3.50 $52,444 No
2015-12-07 Pietzke Steffen Controller and CAO Buy 20,590 $3.64 $74,931 No
2015-08-14 GARCIA PETER S Vice President, CFO Buy 20,000 $5.83 $116,502 No
2014-11-26 SELICK HAROLD E Director Buy 6,000 $8.08 $48,487 No
2011-03-15 Lindell Jody S Director Buy 374 $5.33 $1,992 No
2010-05-14 LARSON CHRISTINE R Vice President and CFO Buy 5,000 $5.71 $28,544 No
2010-04-30 LARSON CHRISTINE R Vice President and CFO Buy 10,000 $6.18 $61,830 No
2009-11-04 KLEIN JOSEPH III Director Sell 24,000 $8.33 $199,815 Yes
2009-06-15 Lindell Jody S Director Buy 3,000 $7.76 $23,280 No
2009-04-08 SANDMAN PAUL W Director Buy 10,000 $7.38 $73,822 No

Insider Smart

Camping World Holdings, Inc (CWH) - Another crash victim, Camping World Holdings, Inc took a deep dive from $16 to $4, several insiders bought around $6. With insiders on your side, this would be an easy add and hold to get your cost under $6. A 300% gain because stock is about to breach $25 in the coming weeks.

Insider Smart

PROSPECT CAPITAL CORP (PSEC) - PSEC is the 2nd most bought stock of the past 90 days by insiders, CEO seems very confident about the company.